PCRX compared with INMD: revenue, margins and what each company keeps, and the suppliers and customers both name

PCRXPacira BioSciences, Inc.

Mkt capRevenueRevenue

INMDInMode Ltd.

Mkt capRevenueRevenue

Compare

PCRXPacira BioSciences, Inc.

INMDInMode Ltd.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

PCRXPacira BioSciences, Inc.

36.40· pre 36.40· delayed

Mkt cap$1.5BRevenue$192MQ2 FY26Revenue$726MFY25

INMDInMode Ltd.

13.31· pre 13.71· delayed

Pre-marketNov 3 '26delayed

Mkt cap$868.0MRevenue—Revenue—

Compare

Pre-marketNov 3 '26delayed

PCRXPacira BioSciences, Inc.

INMDInMode Ltd.

36.40pre 36.40delayed

Price

13.31pre 13.71delayed

$1.5B

Mkt cap

$868.0M

Q2 FY26$192M

Revenue

—

FY25$726M

Revenue

—

PCRX36.40vsINMD13.31Pre-marketNov 3 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

INMD: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PCRX 12

MCKMcKesson Drugcustomer

CAHCardinal Healthcustomer

—AmerisourceBergen Healthunlistedcustomer

JNJJohnson & Johnson MedTechsupplier

8 more · PCRX chain ›

Shared 0

No disclosed counterparties: INMD.

Only INMD 0

None

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

PCRX, solidINMD, dashed